---
input_text: 'Survival and toxicity outcomes of hematopoietic stem cell transplantation
  for pediatric patients with Fanconi anemia: a unified multicentric national study
  from the Spanish Working Group for Bone Marrow Transplantation in Children. Hematopoietic
  stem cell transplantation (HSCT) is currently the only curative option for hematological
  manifestations in patients with Fanconi anemia (FA). We report the outcome of 34
  patients with FA inside a collaborative multicenter national study based on recommendations
  of Spanish Working Group for Bone Marrow Transplantation in Children (GETMON) between
  2009 and 2016. Fludarabine-based conditioning regimen was carried out in all patients,
  with low dose total body irradiation in unrelated transplants. Disease status before
  HSCT was bone marrow failure (BMF) in 30 patients and myelodysplastic syndrome (MDS)
  in four. Donors were matched siblings donors (MSD) in 18, matched unrelated donors
  (MUD) in 15, and one haploidentical donor. All except one patient engrafted. Cumulative
  incidence of grades II-IV acute graft-versus-host disease (GVHD) was 29% and 11%
  for chronic GVHD. Median follow-up after HSCT was 6.5 years. Seven patients (21%)
  died due to transplant-related causes, two (6%) because of MDS relapse, and one
  (3%) after a squamous cell carcinoma. Overall survival (OS) was 73% at 5 years post-transplant,
  with no differences between MSD and MUD transplants. OS for patients with BMF was
  80% while for MDS was 25%. Our data suggest HSCT can cure hematologic manifestations
  of most FA patients with BMF.'
raw_completion_output: |-
  primary_disease: Fanconi anemia
  medical_actions: Hematopoietic stem cell transplantation (HSCT); Fludarabine-based conditioning regimen; Low dose total body irradiation
  symptoms: Bone marrow failure; Myelodysplastic syndrome; Acute graft-versus-host disease; Chronic graft-versus-host disease; MDS relapse; Squamous cell carcinoma
  chemicals: Fludarabine
  action_annotation_relationships: Hematopoietic stem cell transplantation (HSCT) TREATS Bone marrow failure IN Fanconi anemia; Hematopoietic stem cell transplantation (HSCT) TREATS Myelodysplastic syndrome IN Fanconi anemia; Fludarabine-based conditioning regimen TREATS Bone marrow failure IN Fanconi anemia (with Fludarabine); Low dose total body irradiation TREATS Myelodysplastic syndrome IN Fanconi anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Low dose total body irradiation TREATS Myelodysplastic syndrome IN Fanconi anemia

  ===

extracted_object:
  primary_disease: MONDO:0019391
  medical_actions:
    - MAXO:0000747
    - Fludarabine-based conditioning regimen
    - Low dose total body irradiation
  symptoms:
    - HP:0005528
    - HP:0002863
    - Acute graft-versus-host disease
    - Chronic graft-versus-host disease
    - MDS relapse
    - HP:0002860
  chemicals:
    - Fludarabine
  action_annotation_relationships:
    - subject: <Hematopoietic stem cell transplantation>
      predicate: <TREATS>
      object: <Bone marrow failure>
      qualifier: <Fanconi anemia>
      subject_extension: <Hematopoietic stem cell transplantation>
    - subject: MAXO:0000747
      predicate: TREATS
      object: HP:0002863
      qualifier: MONDO:0019391
    - subject: MAXO:0000750
      predicate: TREATS
      object: HP:0005528
      qualifier: MONDO:0019391
      subject_qualifier: Fludarabine-based
      subject_extension: Fludarabine
    - subject: total body irradiation
      predicate: TREATS
      object: HP:0002863
      qualifier: MONDO:0019391
      subject_qualifier: low dose
named_entities:
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: CHEBI:18198
    label: ADCs
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: CHEBI:37153
    label: Calcineurin inhibitor
  - id: CHEBI:38215
    label: Calcium channel blocker
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8069
    label: Phenobarbital
  - id: CHEBI:2668
    label: Amlodipine
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000016
    label: Cellular therapy
  - id: HP:0001871
    label: Blood dyscrasias
  - id: MAXO:0000595
    label: Radiography
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0034057
    label: Congenital defects
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:44185
    label: Methotrexate
  - id: MONDO:0005233
    label: Non-small cell lung cancer (NSCLC)
  - id: CHEBI:33364
    label: Platinum
  - id: MAXO:0000647
    label: chemotherapy
  - id: HP:0030358
    label: Non-small cell lung cancer
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0002863
    label: Myelodysplasia
  - id: HP:0001909
    label: Leukemia
  - id: MONDO:0016624
    label: Hereditary anemia
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005570
    label: Hematological disorders
  - id: HP:0002664
    label: cancer
  - id: MONDO:0015253
    label: Diamond Blackfan anemia
  - id: MAXO:0000600
    label: Kidney replacement therapy (KRT)
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003259
    label: Elevated serum creatinine (SCr > 100micromol/l)
  - id: MONDO:0001529
    label: Bone marrow failure (BMF)
  - id: HP:0002860
    label: oral squamous cell carcinoma (SCC)
  - id: MONDO:0100339
    label: Fanconi anemia (FA)
  - id: CHEBI:28680
    label: Ara-C
  - id: CHEBI:27899
    label: Cisplatin
  - id: HP:0011793
    label: Malignant tumors
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0002745
    label: Oral leukoplakia
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0002910
    label: elevated liver function tests
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:231614
    label: Nivolumab
  - id: CHEBI:25016
    label: PBS
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:28876
    label: Melphalan
  - id: CHEBI:229764
    label: Selinexor
  - id: CHEBI:229762
    label: Eltanexor
  - id: HP:0006775
    label: Multiple Myeloma
  - id: CHEBI:229763
    label: exportin 1 inhibitors
  - id: MONDO:0015909
    label: aplastic anemia
  - id: HP:0004808
    label: Acute myeloid leukaemia
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MONDO:0001881
    label: Septic shock
  - id: MAXO:0001021
    label: Antimicrobial treatment
  - id: MAXO:0000174
    label: Antifungal treatment
  - id: HP:0001876
    label: Pancytopenia
  - id: HP:0001945
    label: Fever
  - id: CHEBI:133748
    label: Citrate
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:33281
    label: Antimicrobial
  - id: CHEBI:35718
    label: Antifungal
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome (PRES)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0001188
    label: Laparoscopy
  - id: HP:0000988
    label: Skin rash
  - id: MONDO:0010161
    label: Tyrosinemia Type 1
  - id: HP:0001919
    label: acute kidney injury (AKI)
  - id: HP:0000822
    label: hypertension
  - id: MAXO:0001298
    label: therapy
  - id: HP:0040012
    label: Increased chromosomal breakage
  - id: MONDO:0004631
    label: Tongue cancer (TC)
  - id: CHEBI:4735
    label: EDTA
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0025085
    label: Blood in stool
  - id: HP:0000568
    label: Microphthalmia
  - id: HP:0000482
    label: microcornea
  - id: HP:0000508
    label: ptosis
  - id: HP:0011496
    label: limbal neovascularization
  - id: HP:0001097
    label: keratoconjunctivitis sicca
  - id: CHEBI:62932
    label: Mycophenolate
  - id: MONDO:0008903
    label: Lung Cancer
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0032169
    label: severe infections
